PCA
XRAY icon

PMV Capital Advisers’s Dentsply Sirona XRAY Stock Holding History

PMV Capital Advisers’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193 Buy
+17
New +$212 ﹤0.01% 92

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

PMV Capital Advisers's XRAY Position: Q1 2026 in Review

PMV Capital Advisers opened a new position in Dentsply Sirona (XRAY) in Q1 2026: 17 shares worth $193. The stake represents ﹤0.01% of the portfolio and ranks #92 among its holdings.

384 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • PMV Capital Advisers held 17 shares of Dentsply Sirona worth $193 as of Q1 2026.
  • Dentsply Sirona was a new PMV Capital Advisers position in Q1 2026.
  • Dentsply Sirona made up ﹤0.01% of PMV Capital Advisers's portfolio in Q1 2026, its #92 holding.
  • 384 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on PMV Capital Advisers's 13F filing for Q1 2026, filed 16 Apr 2026.